News & Events


14th Feb 2017 - Quotient Clinical announces second US acquisition: QS Pharma Quotient Clinical ("Quotient"), the early phase drug develoment services provider, today announces that it has acquired QS Pharma, the contract development and manufacturing organisation (CDMO), based near Philadelphia, US, from Charles River Laboratories International, Inc. Read More